tiprankstipranks
Advertisement
Advertisement

RARE Stock Latest News

Acting FDA head vows to block political interference, Endpoint News says
The FlyActing FDA head vows to block political interference, Endpoint News says
2d ago
AZN
BMY
FDA issues draft guidance to help accelerated cell, gene therapies for patients
PremiumThe Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
4d ago
AZN
BMY
Ultragenyx price target raised to $96 from $84 at Cantor Fitzgerald
PremiumThe Fly
Ultragenyx price target raised to $96 from $84 at Cantor Fitzgerald
17d ago
RARE
Ultragenyx Earnings Call Balances Growth and Cash Burn
PremiumCompany Announcements
Ultragenyx Earnings Call Balances Growth and Cash Burn
18d ago
RARE
Ultragenyx Shareholders Approve Incentive Plan, Elect Directors
PremiumCompany Announcements
Ultragenyx Shareholders Approve Incentive Plan, Elect Directors
19d ago
8K
RARE
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
PremiumThe FlyTrump Trade: Trump to suspend tariff-rate quotas on beef imports
25d ago
AZN
BMY
Trump approves plan to fire FDA head Marty Makary, CBS reports
Premium
The Fly
Trump approves plan to fire FDA head Marty Makary, CBS reports
26d ago
DYN
RNA
Ultragenyx price target lowered to $33 from $34 at Evercore ISI
Premium
The Fly
Ultragenyx price target lowered to $33 from $34 at Evercore ISI
26d ago
RARE
Ultragenyx price target lowered to $26 from $27 at Wedbush
PremiumThe Fly
Ultragenyx price target lowered to $26 from $27 at Wedbush
29d ago
RARE
Ultragenyx price target lowered to $43 from $52 at Guggenheim
PremiumThe Fly
Ultragenyx price target lowered to $43 from $52 at Guggenheim
29d ago
RARE
Ultragenyx Earnings Call: Growth, Gene Therapy and Risk
PremiumCompany Announcements
Ultragenyx Earnings Call: Growth, Gene Therapy and Risk
1M ago
RARE
Ultragenyx price target lowered to $43 from $44 at Barclays
PremiumThe Fly
Ultragenyx price target lowered to $43 from $44 at Barclays
1M ago
RARE
Is RARE a Buy, Before Earnings?
PremiumPre-EarningsIs RARE a Buy, Before Earnings?
1M ago
RARE
Ultragenyx price target raised to $67 from $50 at Morgan Stanley
Premium
The Fly
Ultragenyx price target raised to $67 from $50 at Morgan Stanley
2M ago
RARE
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
Premium
The Fly
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
2M ago
DYN
RNA
Ultragenyx BLA for UX111 Accepted for FDA Review
PremiumCompany Announcements
Ultragenyx BLA for UX111 Accepted for FDA Review
2M ago
8K
RARE
Ultragenyx UX111 AAV9 biologics license application accepted for FDA review
PremiumThe Fly
Ultragenyx UX111 AAV9 biologics license application accepted for FDA review
2M ago
RARE
Ultragenyx Wins FDA IND Clearance for UX016 Therapy
PremiumCompany Announcements
Ultragenyx Wins FDA IND Clearance for UX016 Therapy
2M ago
8K
RARE
Ultragenyx announces FDA clearance of UX016 investigational new drug application
PremiumThe Fly
Ultragenyx announces FDA clearance of UX016 investigational new drug application
2M ago
RARE
Ultragenyx Nears Key Inflection Point With Completed Phase 3 Gene Therapy Study in GSDIa
PremiumCompany AnnouncementsUltragenyx Nears Key Inflection Point With Completed Phase 3 Gene Therapy Study in GSDIa
2M ago
RARE
Midday Fly By: Estee Lauder in deal talks with Puig, Smithfield reports Q4 beat
Premium
The Fly
Midday Fly By: Estee Lauder in deal talks with Puig, Smithfield reports Q4 beat
2M ago
EL
RL
Microsoft reinstated, Ralph Lauren upgraded: Wall Street’s top analyst calls
Premium
The Fly
Microsoft reinstated, Ralph Lauren upgraded: Wall Street’s top analyst calls
2M ago
RL
AJG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >